Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Polycystic Ovary Syndrome 2Neoplasms 2Diabetes Mellitus, Type 2 2Thyroid Cancer, Papillary 1Solid Cancers 1Sezary Syndrome 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Obesity 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Liposarcoma 1Leukoplakia, Oral 1Carcinoma, Renal Cell 1Breast Neoplasms 1Alzheimer Disease 1Adenocarcinoma, Follicular 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 26Cyclophosphamide 20Whole-Body Irradiation 17Mycophenolic Acid 17Cyclosporine 17Tacrolimus 15Busulfan 13Methotrexate 11Antilymphocyte Serum 10Radiotherapy 8Methylprednisolone 8Filgrastim 8Etoposide 8Flow Cytometry 7Bexarotene 7Vorinostat 6Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Carboplatin 5Alemtuzumab 5hypericin 4fludarabine 4Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mycosis Fungoides × Rosiglitazone × Clear all
NCT00178841 2016-02-17

Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

Vanderbilt University

Phase 2 Completed
4 enrolled 5 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡